.
Pharmacogenetics
Study Course Description
Course Description Statuss:Approved
Course Description Version:8.00
Study Course Accepted:16.11.2022 10:41:48
Study Course Information | |||||||||
Course Code: | FKK_001 | LQF level: | Level 7 | ||||||
Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
Branch of Science: | Basic Sciences of Medicine, including Pharmacy | Target Audience: | Pharmacy | ||||||
Study Course Supervisor | |||||||||
Course Supervisor: | Renāte Ranka | ||||||||
Study Course Implementer | |||||||||
Structural Unit: | Department of Pharmaceutical Chemistry | ||||||||
The Head of Structural Unit: | |||||||||
Contacts: | Riga, 16 Dzirciema Street, Block A 5th floor, Room No 502, farmkkrsu[pnkts]lv, +371 67061544 | ||||||||
Study Course Planning | |||||||||
Full-Time - Semester No.1 | |||||||||
Lectures (count) | 8 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 16 | ||||
Classes (count) | 8 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 16 | ||||
Total Contact Hours | 32 | ||||||||
Part-Time - Semester No.1 | |||||||||
Lectures (count) | 8 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 16 | ||||
Classes (count) | 8 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 16 | ||||
Total Contact Hours | 32 | ||||||||
Study course description | |||||||||
Preliminary Knowledge: | In biology, pharmacology and human genetics. | ||||||||
Objective: | To introduce students to the basic concepts of pharmacogenetics, research methods and the application of pharmacogenetics tests in modern health care. | ||||||||
Topic Layout (Full-Time) | |||||||||
No. | Topic | Type of Implementation | Number | Venue | |||||
1 | Introduction into pharmacogenetics | Lectures | 1.00 | auditorium | |||||
2 | Human genetics | Lectures | 1.00 | auditorium | |||||
3 | Pharmacogenetics of drug metabolising enzymes 1 | Lectures | 1.00 | auditorium | |||||
4 | Pharmacogenetics of drug metabolising enzymes 2 | Lectures | 1.00 | auditorium | |||||
5 | Pharmacogenetics of drug metabolising enzymes 3 | Lectures | 1.00 | auditorium | |||||
6 | Cytochrome P450 | Lectures | 1.00 | auditorium | |||||
7 | Pharmacogenetics of drug targets | Lectures | 1.00 | auditorium | |||||
8 | Research in pharmacogenetics | Lectures | 1.00 | auditorium | |||||
9 | Introduction into pharmacogenetics | Classes | 1.00 | laboratory | |||||
10 | Human genetics | Classes | 1.00 | laboratory | |||||
11 | Pharmacogenetics of drug metabolizing enzymes 1 | Classes | 1.00 | laboratory | |||||
12 | Pharmacogenetics of drug metabolizing enzymes 2 | Classes | 1.00 | laboratory | |||||
13 | Pharmacogenetics of drug metabolizing enzymes 3 | Classes | 1.00 | laboratory | |||||
14 | Cytochrome P450 | Classes | 1.00 | laboratory | |||||
15 | Pharmacogenetics of drug targets | Classes | 1.00 | laboratory | |||||
16 | Research in pharmacogenetics | Classes | 1.00 | laboratory | |||||
Topic Layout (Part-Time) | |||||||||
No. | Topic | Type of Implementation | Number | Venue | |||||
1 | Introduction into pharmacogenetics | Lectures | 1.00 | auditorium | |||||
2 | Human genetics | Lectures | 1.00 | auditorium | |||||
3 | Pharmacogenetics of drug metabolising enzymes 1 | Lectures | 1.00 | auditorium | |||||
4 | Pharmacogenetics of drug metabolising enzymes 2 | Lectures | 1.00 | auditorium | |||||
5 | Pharmacogenetics of drug metabolising enzymes 3 | Lectures | 1.00 | auditorium | |||||
6 | Cytochrome P450 | Lectures | 1.00 | auditorium | |||||
7 | Pharmacogenetics of drug targets | Lectures | 1.00 | auditorium | |||||
8 | Research in pharmacogenetics | Lectures | 1.00 | auditorium | |||||
9 | Introduction into pharmacogenetics | Classes | 1.00 | auditorium | |||||
10 | Human genetics | Classes | 1.00 | auditorium | |||||
11 | Pharmacogenetics of drug metabolizing enzymes 1 | Classes | 1.00 | auditorium | |||||
12 | Pharmacogenetics of drug metabolizing enzymes 2 | Classes | 1.00 | auditorium | |||||
13 | Pharmacogenetics of drug metabolizing enzymes 3 | Classes | 1.00 | auditorium | |||||
14 | Cytochrome P450 | Classes | 1.00 | auditorium | |||||
15 | Pharmacogenetics of drug targets | Classes | 1.00 | auditorium | |||||
16 | Research in pharmacogenetics | Classes | 1.00 | auditorium | |||||
Assessment | |||||||||
Unaided Work: | Within the course, the student prepares an independent work using scientific literature (books and scientific publications) in the form of a course work, which is presented in the seminar. Students must fill in the study course evaluation questionnaires. | ||||||||
Assessment Criteria: | The student understands the basic mechanisms of drug effects and side effects, which are related to human genetics. The student is familiar with the basic concepts and basic methods of the subject, knows examples of hereditary variations in the genes of various drug metabolism enzymes and their effect on drug metabolism, knows how to justify with concrete examples the effect of variations in the genes of drug receptors and transport proteins on the effect of drugs. | ||||||||
Final Examination (Full-Time): | Exam (Written) | ||||||||
Final Examination (Part-Time): | Exam (Written) | ||||||||
Learning Outcomes | |||||||||
Knowledge: | As a result of completing the study course, students acquire basic knowledge in the theory of pharmacogenetics, i.e. what is pharmacogenetics, what are the types and goals of pharmacogenetics research, how the characteristics of the human genome can affect the effect of medicinal products on the patient’s body and how medical personnel could predict these effects. | ||||||||
Skills: | As a result of completing the study course, students acquire skills in evaluating the influence of heredity factors in cases of variations in drug action and the ability to search for a solution to the situation. Will be able to explain social and clinical perspectives on interindividual variability in responses to drug substances. | ||||||||
Competencies: | As a result of completing the study course, students gain competence in issues related to the application of human genome research for the provision of personalised pharmacotherapy and the creation of new pharmacogenetic tests, as well as ethical aspects of pharmacogenetics. | ||||||||
Bibliography | |||||||||
No. | Reference | ||||||||
Required Reading | |||||||||
1 | Clinical Applications of Pharmacogenetics. Edited by Despina Sanoudou. Publisher: InTech, 2012. DOI: 10.5772/1277 (Open Access book). (akceptējams izdevums) | ||||||||
2 | Pharmacogenetics. Wendell W. Weber. Oxford Monographs on Medical Genetics, 2nd edition, 2008. (akceptējams izdevums) | ||||||||
Additional Reading | |||||||||
1 | Pharmacogenomics: Social, Ethical, and Clinical Dimensions. Mark A. Rothstein.Wiley-Liss, 2003. | ||||||||
2 | Biochemistry. D.Voet, J.Voet. Wiley, 2021. | ||||||||
3 | Molecular Biology of the Cell. B.Alberts. Garland, 2015. | ||||||||
Other Information Sources | |||||||||
1 | PubMed datu bāze. |